Contract 75D30122C14299
University Of Georgia Research Foundation, Inc. · Department Of Health And Human Services · June 28, 2022
University Of Georgia Research Foundation, Inc. was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on June 28, 2022 for $1000,000 of work in biological product (except diagnostic) manufacturing. Performance is in Athens, GA. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on May 28, 2025. If all options are exercised, the contract could reach $2.25 million.
Contract details
- PIID
- 75D30122C14299
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Athens, GA
- First action
- June 28, 2022
- Latest action
- May 28, 2025
Description
FERRET ANTISERA
Modification timeline
-
May 28, 2025Mod P00004$250.0K
-
March 20, 2025Mod P00003$0
-
April 18, 2024Mod P00002$250.0K
-
May 9, 2023Mod P00001$250.0K
-
June 28, 2022Base award$250.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30122C14299?
Contract 75D30122C14299 is a federal contract awarded to University Of Georgia Research Foundation, Inc. by Department Of Health And Human Services on June 28, 2022 for $1000,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 4 times since the base award.
Who won contract 75D30122C14299?
University Of Georgia Research Foundation, Inc. won contract 75D30122C14299 from Department Of Health And Human Services.
How much is contract 75D30122C14299 worth?
Contract 75D30122C14299 has obligated $1000,000 to date, with a total potential value of $2.25 million if all options are exercised.